Ralph Mocikat
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Immune checkpoint blockade impairs immunosuppressive mechanisms of regulatory T cells in B-cell lymphoma.
Journal: Translational oncology
Published: June 29, 2021
Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence.
Journal: Journal for immunotherapy of cancer
Published: December 10, 2020
The role of dendritic cells for therapy of B-cell lymphoma with immune checkpoint inhibitors.
Journal: Cancer immunology, immunotherapy : CII
Published: June 08, 2020
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours.
Journal: Nature communications
Published: November 26, 2018
Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-γ and induces NK cell-dependent lymphoma control without other immunotherapies.
Journal: International journal of cancer
Published: December 22, 2016
Potent CD4+ T cell-associated antitumor memory responses induced by trifunctional bispecific antibodies in combination with immune checkpoint inhibition.
Journal: Oncotarget
Published: July 25, 2016
Efficacy and Tolerability of a GD2-Directed Trifunctional Bispecific Antibody in a Preclinical Model: Subcutaneous Administration Is Superior to Intravenous Delivery.
Journal: Molecular cancer therapeutics
Published: February 17, 2015
Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.
Journal: European journal of immunology
Published: November 27, 2014
CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.
Journal: International journal of cancer
Published: February 24, 2014
Last Updated: 09/26/2026